1. Home
  2. ENTX vs LVO Comparison

ENTX vs LVO Comparison

Compare ENTX & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.18

Market Cap

62.6M

Sector

Health Care

ML Signal

HOLD

Logo LiveOne Inc.

LVO

LiveOne Inc.

HOLD

Current Price

$5.13

Market Cap

62.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
LVO
Founded
2010
2009
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
62.6M
62.8M
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
ENTX
LVO
Price
$1.18
$5.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.00
$11.50
AVG Volume (30 Days)
135.1K
82.8K
Earning Date
05-14-2026
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
78.57
EPS
0.25
N/A
Revenue
$42,000.00
$114,405,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$23.04
P/E Ratio
$4.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$0.43
52 Week High
$3.22
$6.04

Technical Indicators

Market Signals
Indicator
ENTX
LVO
Relative Strength Index (RSI) 47.82 51.46
Support Level $0.96 $3.99
Resistance Level $1.38 $5.69
Average True Range (ATR) 0.10 0.43
MACD -0.00 0.07
Stochastic Oscillator 23.08 48.95

Price Performance

Historical Comparison
ENTX
LVO

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

About LVO LiveOne Inc.

LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.

Share on Social Networks: